Collaboration will explore trans-arterial delivery of Imugene's CF33 oncolytic virus utilizing RenovoRx's TAMP therapy platformTAMP enables localized, targeted delivery of CF33 to difficult-to-access tumors, such as pancreatic and liver
Renovorx And Imugene Announce Collaboration To Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (Tamptm) Platform menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Renovorx And Imugene Announce Collaboration To Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (Tamp) Platform menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.